{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T10:03:58Z","timestamp":1790157838606,"version":"4.1.0"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":190,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-22-EXPR0013"],"award-info":[{"award-number":["ANR-22-EXPR0013"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-23-IAHU-0010"],"award-info":[{"award-number":["ANR-23-IAHU-0010"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007871","name":"European College of Neuropsychopharmacology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI21\/01929"],"award-info":[{"award-number":["PI21\/01929"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008062","name":"Fundaci\u00f3n Alicia Koplowitz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006301","name":"Center for International Business Education and Research, University of Illinois at Urbana-Champaign","doi-asserted-by":"publisher","award":["CB\/07\/09\/0023"],"award-info":[{"award-number":["CB\/07\/09\/0023"]}],"id":[{"id":"10.13039\/100006301","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008722","name":"Universitat de Girona","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008722","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"HORIZON EUROPE Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Applied"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.nsa.2026.107021","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T23:34:19Z","timestamp":1783726459000},"page":"107021","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Outcome strategies for clinical trials in Neuropaediatric rare diseases"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8914-7401","authenticated-orcid":false,"given":"Maria Teresa","family":"Acosta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7779-7626","authenticated-orcid":false,"given":"Jos\u00e9 \u00c1ngel","family":"Aibar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celso","family":"Arango","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estibaliz Arce","family":"Cirauqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Baeza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Berry-Kravis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim I.","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Busner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2577-390X","authenticated-orcid":false,"given":"Chere","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Chaumette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00e9s","family":"del Cerro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Carlos","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Dorffner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5638-9188","authenticated-orcid":false,"given":"Chris J.","family":"Edgar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Giorgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4878-5241","authenticated-orcid":false,"given":"Sabine M.","family":"H\u00f6lter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3057-6150","authenticated-orcid":false,"given":"Sarah","family":"Kittel-Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1175-8090","authenticated-orcid":false,"given":"Robert D.","family":"Latzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0541-4846","authenticated-orcid":false,"given":"Carmen","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Pallanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlotta","family":"Colzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2868-8850","authenticated-orcid":false,"given":"Carme","family":"Plasencia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Radtke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Rockwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Santuccione Chadha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9282-0230","authenticated-orcid":false,"given":"Gunes","family":"Sevinc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4373-3293","authenticated-orcid":false,"given":"Manpreet K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne H.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.K.","family":"Tandon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniella","family":"Tinoco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5520-7770","authenticated-orcid":false,"given":"Eleonora","family":"Broggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Fontecha","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8173-7564","authenticated-orcid":false,"given":"Igor","family":"Magaraggia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8568-4696","authenticated-orcid":false,"given":"Silvia","family":"Zaragoza Domingo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nsa.2026.107021_bib1","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/S1474-4422(13)70179-0","article-title":"Challenges of cognitive research in neurofibromatosis type 1","volume":"12","author":"Acosta","year":"2013","journal-title":"Lancet Neurol."},{"issue":"Suppl. 4","key":"10.1016\/j.nsa.2026.107021_bib2","first-page":"52","article-title":"Rare diseases and undiagnosed diseases: advances in neurodevelopment","volume":"83","author":"Acosta","year":"2023","journal-title":"Medicina (B. Aires)"},{"key":"10.1016\/j.nsa.2026.107021_bib3","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.pediatrneurol.2011.06.016","article-title":"Lovastatin as treatment for neurocognitive deficits in neurofibromatosis type 1: phase I study","volume":"45","author":"Acosta","year":"2011","journal-title":"Pediatr. Neurol."},{"issue":"1","key":"10.1016\/j.nsa.2026.107021_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-025-03814-0","article-title":"Methodological challenges in outcomes research for early-trials for implementation of new therapies in neuropediatric rare diseases","volume":"20","author":"Acosta","year":"2025","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.nsa.2026.107021_bib5","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.3390\/jcm9051334","article-title":"Machine learning enables prediction of cardiac amyloidosis by routine laboratory parameters: a proof-of-concept study","volume":"9","author":"Agibetov","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.nsa.2026.107021_bib6","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s00335-023-10010-7","article-title":"INFRAFRONTIER: Mouse model resources for modelling human diseases","volume":"34","author":"Ali Khan","year":"2023","journal-title":"Mamm. Genome"},{"key":"10.1016\/j.nsa.2026.107021_bib7","unstructured":"Apple, New holistic Apple Health Study launches today in the Research app - Apple, (n.d.). https:\/\/www.apple.com\/newsroom\/2025\/02\/new-holistic-apple-health-study-launches-today-in-the-research-app\/(accessed September 12, 2025)."},{"key":"10.1016\/j.nsa.2026.107021_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinthera.2016.04.001","article-title":"Engaging participants in rare disease research: a qualitative study of Duchenne muscular dystrophy","volume":"38","author":"Bendixen","year":"2016","journal-title":"Clin. Ther."},{"key":"10.1016\/j.nsa.2026.107021_bib9","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.jval.2017.05.015","article-title":"Patient-reported outcome and observer-reported outcome assessment in rare disease clinical trials: an ISPOR COA emerging good practices task force report","volume":"20","author":"Benjamin","year":"2017","journal-title":"Value Health"},{"key":"10.1016\/j.nsa.2026.107021_bib10","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.3389\/fpsyg.2016.01710","article-title":"The agreement between parent-reported and directly measured child language and parenting behaviors","volume":"7","author":"Bennetts","year":"2016","journal-title":"Front. Psychol."},{"key":"10.1016\/j.nsa.2026.107021_bib13","first-page":"25","article-title":"Patient centricity: design and conduct of clinical trials in orphan diseases: third of three sets of expanded proceedings from the 2020 ISCTM autumn conference on pediatric drug development","volume":"20","author":"Busner","year":"2023","journal-title":"Innov. Clin. Neurosci."},{"key":"10.1016\/j.nsa.2026.107021_bib12","first-page":"15","article-title":"Clinician- and patient-reported endpoints in CNS orphan drug clinical trials: ISCTM position paper on best practices for endpoint selection, validation, training, and standardization","volume":"18","author":"Busner","year":"2021","journal-title":"Innov. Clin. Neurosci."},{"key":"10.1016\/j.nsa.2026.107021_bib11","first-page":"28","article-title":"The clinical global impressions scale: applying a research tool in clinical practice","volume":"4","author":"Busner","year":"2007","journal-title":"Psychiatry (Edgmont)"},{"key":"10.1016\/j.nsa.2026.107021_bib14","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.ajhg.2023.06.013","article-title":"Monoallelic variation in DHX9, the gene encoding the DExH-box helicase DHX9, underlies neurodevelopment disorders and Charcot-Marie-Tooth disease","volume":"110","author":"Calame","year":"2023","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.nsa.2026.107021_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.580314","article-title":"Evaluation of bone age in children: a mini-review","volume":"9","author":"Cavallo","year":"2021","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.nsa.2026.107021_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41687-024-00716-w","article-title":"A systematic review of goal attainment scaling implementation practices by caregivers in randomized controlled trials","volume":"8","author":"Cheema","year":"2024","journal-title":"J. Patient-Rep. Outcomes"},{"key":"10.1016\/j.nsa.2026.107021_bib17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1037\/0894-4105.7.1.41","article-title":"Individual change after epilepsy surgery: practice effects and base-rate information","volume":"7","author":"Chelune","year":"1993","journal-title":"Neuropsychology"},{"key":"10.1016\/j.nsa.2026.107021_bib18","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jclinepi.2019.02.004","article-title":"A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models","volume":"110","author":"Christodoulou","year":"2019","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.nsa.2026.107021_bib19","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/ceo.13022","article-title":"Novel mobility test to assess functional vision in patients with inherited retinal dystrophies","volume":"46","author":"Chung","year":"2018","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.nsa.2026.107021_bib20","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/arclin\/acaa104","article-title":"Development of standardized regression-based formulas to assess meaningful cognitive change in early Parkinson's disease","volume":"36","author":"Combs","year":"2021","journal-title":"Arch. Clin. Neuropsychol."},{"key":"10.1016\/j.nsa.2026.107021_bib25","article-title":"GM1 gangliosidosis type II: results of a 10-year prospective study","volume":"26","author":"D'Souza","year":"2024","journal-title":"Genet. Med."},{"key":"10.1016\/j.nsa.2026.107021_bib74","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s00335-023-09986-z","article-title":"Knockout mouse models as a resource for the study of rare diseases","volume":"34","author":"da Silva-Buttkus","year":"2023","journal-title":"Mamm. Genome"},{"issue":"Suppl. 3","key":"10.1016\/j.nsa.2026.107021_bib21","first-page":"S49","article-title":"Dravet syndrome: early electroclinical findings and long-term outcome in adolescents and adults","volume":"60","author":"Darra","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.nsa.2026.107021_bib22","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s40271-021-00569-1","article-title":"Time to see the difference: video capture for patient-centered clinical trials","volume":"15","author":"Davies","year":"2022","journal-title":"Patient"},{"key":"10.1016\/j.nsa.2026.107021_bib56","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev-clinpsy-050212-185617","article-title":"Principles underlying the use of multiple informants' reports","volume":"9","author":"De Los Reyes","year":"2013","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"10.1016\/j.nsa.2026.107021_bib88","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3899\/jrheum.130816","article-title":"What has been the effect on trial outcome assessments of a decade of patient participation in OMERACT?","volume":"41","author":"De Wit","year":"2014","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.nsa.2026.107021_bib23","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1111\/epi.18440","article-title":"Appropriate selection of participants in pediatric developmental and epileptic encephalopathy trials: lessons learned and future opportunities","volume":"66","author":"Dlugos","year":"2025","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.nsa.2026.107021_bib24","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1186\/s13063-024-08678-6","article-title":"International workshop: what is needed to ensure outcome measures for Rett syndrome are fit-for-purpose for clinical trials? June 7, 2023, Nashville, USA","volume":"25","author":"Downs","year":"2024","journal-title":"Trials"},{"key":"10.1016\/j.nsa.2026.107021_bib26","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1751-9004.2009.00194.x","article-title":"An introduction to item response theory using the need for cognition scale","volume":"3","author":"Edwards","year":"2009","journal-title":"Soc. Personal. Psychol. Compass"},{"issue":"10","key":"10.1016\/j.nsa.2026.107021_bib27","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s40264-021-01079-7","article-title":"Patient global impression of benefit\u2013risk (PGI-BR): incorporating patients' views of clinical benefit\u2013risk into assessment of new medicines","volume":"44","author":"Eek","year":"2021","journal-title":"Drug Saf."},{"key":"10.1016\/j.nsa.2026.107021_bib28","doi-asserted-by":"crossref","DOI":"10.3758\/s13428-025-02626-1","article-title":"ESM-Q: a consensus-based quality assessment tool for experience sampling method items","volume":"57","author":"Eisele","year":"2025","journal-title":"Behav. Res. Methods"},{"key":"10.1016\/j.nsa.2026.107021_bib29","unstructured":"EMA and FDA Set Common Principles for AI in Medicine Development | European Medicines Agency (EMA), (n.d.). https:\/\/www.ema.europa.eu\/en\/news\/ema-fda-set-common-principles-ai-medicine-development-0 (accessed June 27, 2026)."},{"key":"10.1016\/j.nsa.2026.107021_bib30","series-title":"Contemporary Issues in Evaluating Treatment in Neurodevelopmental Disorders","author":"Esbensen","year":"2022"},{"key":"10.1016\/j.nsa.2026.107021_bib33","first-page":"1","article-title":"Psychometric perspectives on developmental outcome and endpoint selection in treatment trials for genetic conditions associated with neurodevelopmental disorder","volume":"62","author":"Farmer","year":"2022","journal-title":"Int. Rev. Res. Dev. Disabil."},{"key":"10.1016\/j.nsa.2026.107021_bib32","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1352\/1944-7558-125.6.475","article-title":"Person ability scores as an alternative to norm-referenced scores as outcome measures in studies of neurodevelopmental disorders","volume":"125","author":"Farmer","year":"2020","journal-title":"Am. J. Intellect. Dev. Disabil."},{"key":"10.1016\/j.nsa.2026.107021_bib34","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1007\/s11606-014-2895-9","article-title":"A systematic review of approaches for engaging patients for research on rare diseases","volume":"29","author":"Forsythe","year":"2014","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.nsa.2026.107021_bib35","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1111\/2041-210X.12584","article-title":"BORIS: a free, versatile open-source event-logging software for video\/audio coding and live observations","volume":"7","author":"Friard","year":"2016","journal-title":"Methods Ecol. Evol."},{"key":"10.1016\/j.nsa.2026.107021_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12874-019-0866-x","article-title":"Goal attainment scaling as an outcome measure in rare disease trials: a conceptual proposal for validation","volume":"19","author":"Gaasterland","year":"2019","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.nsa.2026.107021_bib37","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ymgme.2016.01.007","article-title":"The NIH undiagnosed diseases program and network: applications to modern medicine","volume":"117","author":"Gahl","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.nsa.2026.107021_bib38","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jval.2020.10.023","article-title":"A patient-centric tool to facilitate goal attainment scaling in neurogenic bladder and bowel dysfunction: path to individualization","volume":"24","author":"Goldstine","year":"2021","journal-title":"Value Health"},{"key":"10.1016\/j.nsa.2026.107021_bib39","series-title":"ECDEU Assessment Manual for Psychopharmacology, Rev., Rockville, Md. : U. S. Dept. of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration","author":"Guy","year":"1976"},{"key":"10.1016\/j.nsa.2026.107021_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jcm10040861","article-title":"Early diagnostics and early intervention in neurodevelopmental Disorders\u2014age-dependent challenges and opportunities","volume":"10","author":"Hadders-Algra","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.nsa.2026.107021_bib41","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/00004583-199203000-00002","article-title":"Specificity of inattention, impulsivity, and hyperactivity to the diagnosis of attention-deficit hyperactivity disorder","volume":"31","author":"Halperin","year":"1992","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.nsa.2026.107021_bib42","first-page":"13","article-title":"Special challenges in pediatric drug development: first of three sets of expanded proceedings from the ISCTM autumn conference on pediatric drug development","volume":"20","author":"Harvey","year":"2023","journal-title":"Innov. Clin. Neurosci."},{"key":"10.1016\/j.nsa.2026.107021_bib43","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-024-08100-1","article-title":"A methodological review of randomised n-of-1 trials","volume":"25","author":"Hawksworth","year":"2024","journal-title":"Trials"},{"key":"10.1016\/j.nsa.2026.107021_bib44","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1080\/13854046.2010.526785","article-title":"Official position of the American academy of clinical neuropsychology on serial neuropsychological assessments: the utility and challenges of repeat test administrations in clinical and forensic contexts","volume":"24","author":"Heilbronner","year":"2010","journal-title":"Clin. Neuropsychol."},{"key":"10.1016\/j.nsa.2026.107021_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2025.104388","article-title":"Insights from the European medicines agency on digital health technology derived endpoints","volume":"30","author":"Jadoenathmisier","year":"2025","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.nsa.2026.107021_bib46","article-title":"Artificial intelligence and electronic health records: a narrative review of current applications and challenges in pediatric surgery","volume":"8","author":"Javed","year":"2025","journal-title":"World J. Plast. Surg."},{"key":"10.1016\/j.nsa.2026.107021_bib47","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1017\/BrImp.2017.31","article-title":"An introduction to item response theory and rasch analysis: application using the Eating Assessment Tool (EAT-10)","volume":"19","author":"Kean","year":"2018","journal-title":"Brain Impair."},{"issue":"1","key":"10.1016\/j.nsa.2026.107021_bib48","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1186\/s13023-025-04048-w","article-title":"Basket trials in rare diseases: a systematic review of current practices, methodological challenges, and future directions","volume":"20","author":"Khazen","year":"2025","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.nsa.2026.107021_bib49","doi-asserted-by":"crossref","first-page":"59","DOI":"10.5493\/wjem.v13.i4.59","article-title":"Neurologic orphan diseases: emerging innovations and role for genetic treatments","volume":"13","author":"Kioutchoukova","year":"2023","journal-title":"World J. Exp. Med."},{"key":"10.1016\/j.nsa.2026.107021_bib51","series-title":"Goal Attainment Scaling : Applications, Theory, and Measurement","author":"Kiresuk","year":"2014"},{"key":"10.1016\/j.nsa.2026.107021_bib50","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/BF01530764","article-title":"Goal attainment scaling: a general method for evaluating comprehensive community mental health programs","volume":"4","author":"Kiresuk","year":"1968","journal-title":"Community Ment. Health J."},{"issue":"1","key":"10.1016\/j.nsa.2026.107021_bib52","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13229-022-00493-7","article-title":"Clinical trial of insulin-like growth factor-1 in Phelan-McDermid syndrome","volume":"13","author":"Kolevzon","year":"2022","journal-title":"Mol. Autism"},{"key":"10.1016\/j.nsa.2026.107021_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242115821","article-title":"Animal models of human disease","volume":"24","author":"Lange","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.nsa.2026.107021_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-025-03614-6","article-title":"Retrospective assessment of clinical global impression of severity and change in GM1 gangliosidosis: a tool to score natural history data in rare disease cohorts","volume":"20","author":"Lewis","year":"2025","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.nsa.2026.107021_bib55","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1002\/jcph.2134","article-title":"Natural history and real-world data in rare diseases: applications, limitations, and future perspectives","volume":"62","author":"Liu","year":"2022","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.nsa.2026.107021_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/brainsci10090629","article-title":"Response to placebo in fragile X syndrome clinical trials: an initial analysis","volume":"10","author":"Luu","year":"2020","journal-title":"Brain Sci."},{"issue":"10","key":"10.1016\/j.nsa.2026.107021_bib58","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1007\/s42399-021-00989-y","article-title":"Comorbidities in Dravet Syndrome and lennox\u2013gastaut syndrome","volume":"3","author":"Marchese","year":"2021","journal-title":"SN Compr. Clin. Med."},{"key":"10.1016\/j.nsa.2026.107021_bib59","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1080\/13854049308401901","article-title":"\u201cT scores for change\u201d: an illustration of a regression approach to depicting change in clinical neuropsychology","volume":"7","author":"McSweeny","year":"1993","journal-title":"Clin. Neuropsychol."},{"key":"10.1016\/j.nsa.2026.107021_bib60","series-title":"The Leeds Reliable Change Indicator - Simple Excel (Tm) Applications for the Analysis of Individual Patient and Group Data","author":"Morley","year":"2014"},{"key":"10.1016\/j.nsa.2026.107021_bib61","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/978-981-15-2389-2_9","article-title":"Animal model contributions to congenital metabolic disease","volume":"1236","author":"Moro","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.nsa.2026.107021_bib62","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jval.2022.11.012","article-title":"Approaches to the assessment of clinical benefit of treatments for conditions that have heterogeneous symptoms and impacts: potential applications in rare disease","volume":"26","author":"Murray","year":"2023","journal-title":"Value Health"},{"key":"10.1016\/j.nsa.2026.107021_bib63","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1177\/0883073815579707","article-title":"Improving treatment trial outcomes for Rett Syndrome: the development of rett-specific anchors for the clinical global impression scale","volume":"30","author":"Neul","year":"2015","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.nsa.2026.107021_bib64","first-page":"18","article-title":"Implications of pediatric initiatives on CNS drug development for all Ages\u20142020 and beyond: second of three sets of expanded proceedings from the 2020 ISCTM autumn conference on pediatric drug development","volume":"20","author":"Pandina","year":"2023","journal-title":"Innov. Clin. Neurosci."},{"key":"10.1016\/j.nsa.2026.107021_bib65","first-page":"52","article-title":"Ensuring stakeholder feedback in the design and conduct of clinical trials for rare diseases: ISCTM position paper of the Orphan Disease Working Group","volume":"21","author":"Pandina","year":"2024","journal-title":"Innov. Clin. Neurosci."},{"key":"10.1016\/j.nsa.2026.107021_bib66","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2147\/IBPC.S152761","article-title":"White coat syndrome and its variations: differences and clinical impact","volume":"11","author":"Pioli","year":"2018","journal-title":"Integrated Blood Pres. Control"},{"key":"10.1016\/j.nsa.2026.107021_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2025.1649114","article-title":"Mass medicine vs. personalized medicine: from mathematical methods to regulatory implications","volume":"16","author":"Randhawa","year":"2025","journal-title":"Front. Physiol."},{"issue":"1","key":"10.1016\/j.nsa.2026.107021_bib68","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s40271-020-00455-2","article-title":"Generating relevant information from patients in the technology-enhanced era of patient-focused drug development: opportunities and challenges","volume":"14","author":"Reaney","year":"2020","journal-title":"The Patient - Patient-Centered Outcomes Research"},{"key":"10.1016\/j.nsa.2026.107021_bib69","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/hae.14608","article-title":"The GOAL-H\u0113m journey: shared decision making and patient-centred outcomes","volume":"28","author":"Roberts","year":"2022","journal-title":"Haemophilia"},{"key":"10.1016\/j.nsa.2026.107021_bib70","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","article-title":"Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial","volume":"390","author":"Russell","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.nsa.2026.107021_bib72","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jval.2024.12.004","article-title":"The feasibility of personalized endpoints in assessing treatment outcomes for rare diseases: a pilot study of goal attainment scaling in SCN2A-Associated developmental epileptic encephalopathy","volume":"28","author":"Sevinc","year":"2025","journal-title":"Value Health"},{"key":"10.1016\/j.nsa.2026.107021_bib71","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jval.2024.10.020","article-title":"P16 standardized implementation of a personalized endpoint: Inventory-Facilitated goal attainment scaling","volume":"27","author":"Sevinc","year":"2024","journal-title":"Value Health"},{"key":"10.1016\/j.nsa.2026.107021_bib73","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/bcp.15907","article-title":"Patient-reported, observer-reported and performance outcomes in qualification procedures at the European medicines agency 2013\u20132018","volume":"90","author":"Silva","year":"2024","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.nsa.2026.107021_bib75","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/humu.22844","article-title":"GeneMatcher: a matching tool for connecting investigators with an interest in the same gene","volume":"36","author":"Sobreira","year":"2015","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.nsa.2026.107021_bib76","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1592011","article-title":"Repurposing nicardipine leads to improved development in a young patient with Pitt\u2013Hopkins syndrome","volume":"16","author":"Somorai","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.nsa.2026.107021_bib77","doi-asserted-by":"crossref","DOI":"10.1177\/13623613251349904","article-title":"Development of a Goal Attainment Scale (GAS) outcome measure for clinical interventional studies in paediatric autism","author":"Staunton","year":"2025","journal-title":"Autism"},{"issue":"1","key":"10.1016\/j.nsa.2026.107021_bib78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-07229-3","article-title":"Neural network analysis of sleep stages enables efficient diagnosis of narcolepsy","volume":"9","author":"Stephansen","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nsa.2026.107021_bib79","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1007\/s43441-024-00693-8","article-title":"A framework for the use and likelihood of regulatory acceptance of single-arm trials","volume":"58","author":"Subramaniam","year":"2024","journal-title":"Ther. Innov. Regul. Sci."},{"key":"10.1016\/j.nsa.2026.107021_bib80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-021-01805-5","article-title":"The multi-domain responder index: a novel analysis tool to capture a broader assessment of clinical benefit in heterogeneous complex rare diseases","volume":"16","author":"Tandon","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.nsa.2026.107021_bib81","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1007\/s10072-020-04995-1","article-title":"Possible tics diagnosed as stereotypies in patients with severe autism spectrum disorder: a video-based evaluation","volume":"42","author":"Termine","year":"2021","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.nsa.2026.107021_bib82","unstructured":"U.S. Food & Drug Administration (FDA), Patient-Focused Drug Development: Methods to Identify what Is Important to Patients | FDA, (n.d.). https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/patient-focused-drug-development-methods-identify-what-important-patients (accessed September 9, 2025)."},{"key":"10.1016\/j.nsa.2026.107021_bib83","unstructured":"U.S. Food and Drug Administration, Digital Health Technologies for Remote Data Acquisition in Clinical Investigations, (n.d.). https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/digital-health-technologies-remote-data-acquisition-clinical-investigations (accessed November 21, 2025)."},{"key":"10.1016\/j.nsa.2026.107021_bib85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13063-021-05305-6","article-title":"Parent engagement in co-design of clinical trials: the PARENT trial","volume":"22","author":"Vanderloo","year":"2021","journal-title":"Trials"},{"key":"10.1016\/j.nsa.2026.107021_bib86","article-title":"RARE-X: a patient-driven approach for collecting symptom and patient-reported outcome data in rare diseases","author":"Vogel-Farley","year":"2025","journal-title":"Genet. Med."},{"key":"10.1016\/j.nsa.2026.107021_bib87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13063-017-1978-4","article-title":"The COMET handbook: version 1.0","volume":"18","author":"Williamson","year":"2017","journal-title":"Trials"},{"key":"10.1016\/j.nsa.2026.107021_bib89","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jpeds.2004.01.046","article-title":"Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human \u03b1-L-iduronidase (laronidase)","volume":"144","author":"Wraith","year":"2004","journal-title":"J. Pediatr."},{"key":"10.1016\/j.nsa.2026.107021_bib90","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.euroneuro.2024.02.009","article-title":"Methods for neuroscience drug development: guidance on standardization of the process for defining clinical outcome strategies in clinical trials","volume":"83","author":"Zaragoza Domingo","year":"2024","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.nsa.2026.107021_bib91","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-24040-5","article-title":"Insights from 24-hour actigraphy using functional linear modeling in children with and without ADHD","volume":"15","author":"Ziegler","year":"2025","journal-title":"Sci. Rep."}],"container-title":["Neuroscience Applied"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772408526001407?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772408526001407?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T09:17:52Z","timestamp":1790155072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772408526001407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":89,"alternative-id":["S2772408526001407"],"URL":"https:\/\/doi.org\/10.1016\/j.nsa.2026.107021","relation":{},"ISSN":["2772-4085"],"issn-type":[{"value":"2772-4085","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcome strategies for clinical trials in Neuropaediatric rare diseases","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Applied","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nsa.2026.107021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European College of Neuropsychopharmacology.","name":"copyright","label":"Copyright"}],"article-number":"107021"}}